NCT01400048

Aloe Vera in Irritable Bowel Syndrome

Aloe Vera Versus Placebo for Patients With Irritable Bowel Syndrome

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 173 (actual)
• Sponsor: Sahlgrenska University Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the present study is to study the effect of aloe vera in the treatment of IBS patients in a randomized, double-blind placebo controlled study.

Detailed description

There is limited knowledge of the IBS pathophysiology, absence of biological markers and therefore few effective treatment options. IBS therefore contributes to difficulties in the management of the patients. Aloe vera has a long association with herbal medicine, from the Ebers Papyrus from 16th century BCE. It is alleged to be effective in treatment of wounds, to improve blood glucose levels in diabetics, and it may reduce symptoms and inflammation in patients with ulcerative colitis. Evidence of the effects of aloe vera in the treatment of IBS, is however limited and contradictory.

Conditions

• Irritable Bowel Syndrome

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Aloe vera effervescent tablet (AVH200)	250 mg aloe vera and 60 mg ascorbic acid, Aloe Life®
DIETARY_SUPPLEMENT	Placebo control	60mg Ascorbic acid

Timeline

• Start date: 2010-01-01
• Primary completion: 2016-12-01
• Completion: 2017-03-01
• First posted: 2011-07-22
• Last updated: 2018-09-10

Locations

1 site across 1 country: Sweden